Recent News for ACER - Acer Therapeutics Inc.

Date Title
May 29 Is Acer Therapeutics Inc. (ACER) A Good Stock To Buy?
May 21 Acer Therapeutics Discusses Developing COVID-19 Clinical Program, Next Steps with the FDA and Vision for 2020 in New Video Interview on SNN Network
May 14 Acer Therapeutics EPS misses by $0.09
May 14 Acer Therapeutics Reports First Quarter 2020 Financial Results and Provides Corporate Update
May 12 60 Stocks Moving In Tuesday's Mid-Day Session
May 12 The Daily Biotech Pulse: NASH Disappointment For Genfit, Novavax Lands $384M CEPI Funding For Coronavirus Vaccine, GW Pharma Earnings
May 12 Acer to investigate use of emetine in COVID-19
May 11 Acer Therapeutics to Develop Emetine as Potential COVID-19 Treatment in Collaboration with National Center for Advancing Translational Sciences, One of the National Institutes of Health
Apr 30 Acer Therapeutics Announces Common Stock Purchase Agreement for up to $15 million with Lincoln Park Capital
Mar 25 Acer Therapeutics: EDSIVO Appeal Denied But FDA Door Remains Open
Mar 20 The Daily Biotech Pulse: Mylan Ramps Up Manufacturing Of Potential COVID-19 Drug, Lexicon Stops Study Early, Masimo To Buy German Ventilation Company
Mar 20 111 Biggest Movers From Yesterday
Mar 19 Mid-Afternoon Market Update: NASDAQ Jumps 4%; Guess? Shares Climb On Earnings Beat
Mar 19 Mid-Day Market Update: Crude Oil Surges Over 17%; G-III Apparel Shares Gain On Upbeat Earnings
Mar 19 92 Stocks Moving In Thursday's Mid-Day Session
Mar 18 FDA denies Acer appeal of CRL
Mar 18 Acer Therapeutics EPS misses by $0.03
Mar 18 Acer Therapeutics Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Corporate Update
Mar 18 Acer Receives Formal Dispute Resolution Request (FDRR) Response from FDA’s Office of New Drugs
Feb 26 eSports Platform Planet9 Now Open for Registration at Intel Extreme Masters in Katowice
Feb 25 Mallinckrodt among healthcare gainers; Tocagen and Clovis Oncology among losers
Feb 25 Play Like the Pros with the Official Predator IEM PCs
Feb 24 14 Stocks Moving In Monday's After-Hours Session
Feb 24 Acer Therapeutics Announces ACER-001 for Urea Cycle Disorders Trial Shows Bioequivalence to BUPHENYL®
Feb 24 94 Biggest Movers From Friday

Back to the Main ACER Page...